Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

A murine model of invasive aspergillosis: variable benefit of interferon-gamma administration under in vitro and in vivo conditions. Surg Infect (Larchmt) 2005;6(4):397-407

Date

01/26/2006

Pubmed ID

16433604

DOI

10.1089/sur.2005.6.397

Scopus ID

2-s2.0-33144462780   4 Citations

Abstract

BACKGROUND: Interferon-gamma modulates host defense in a number of infectious diseases. Previous studies have shown that systemic administration of interferon-gamma (IFN-gamma) can enhance survival in experimental invasive aspergillosis (IA).

METHODS: Using a novel model of murine IA that is characterized by primary pulmonary infection, we investigated the role of IFN-gamma in the phagocytosis and killing of Aspergillus fumigatus by murine neutrophils and pulmonary alveolar macrophages in vitro and the impact of systemic and regional administration of IFN-gamma on the course of IA in glucocorticoid-treated mice.

RESULTS: In vitro, IFN-gamma significantly enhanced phagocytosis and killing function of both neutrophils and alveolar macrophages from normal animals, but not cortisone-treated animals. In vivo, intravenous administration of IFN-gamma did not improve phagocyte recruitment, in vivo killing, or mortality from IA. Regional (intranasal) administration of IFN-gamma to the lungs enhanced recruitment of phagocytic cells to the lungs and improved in vivo killing, but did not alter (and actually worsened) mortality from IA.

CONCLUSIONS: The in vitro and in vivo effects of IFN-gamma in IA are contingent on many variables, including the route of administration and the specific pathogenesis of infection.

Author List

Johnson CP, Edmiston CE Jr, Zhu YR, Adams MB, Roza AM, Kurup V

Authors

Christopher P. Johnson MD Professor in the Surgery department at Medical College of Wisconsin
Allan M. Roza MD Professor in the Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Aspergillosis
Aspergillus fumigatus
Disease Models, Animal
Female
Humans
Interferon-gamma
Lung
Lung Diseases, Fungal
Macrophages, Alveolar
Mice
Mice, Inbred BALB C
Neutrophils
Phagocytosis
Recombinant Proteins
Specific Pathogen-Free Organisms
Spores, Fungal
Treatment Outcome
jenkins-FCD Prod-478 d1509cf07a111124a2d122fd3df854cc0b993c00